Company Intelligence
Absci
Absci provides enterprise-grade artificial intelligence solutions, delivering specialized Absci Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Vancouver, United States
- Website
- www.absci.com
- Founded
- 2011
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Absci is a Healthcare AI company based in Vancouver, United States, founded in 2011.
Vancouver, Washington biotechnology company designing clinical-stage biologics with generative AI drug creation platform.
Verified founder profile on Brel: Sean McClain.
What it builds
Absci Platform
Why It Matters
Absci provides enterprise-grade artificial intelligence solutions, delivering specialized Absci Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Absci — Biotechnology
Explore Absci — Biotechnology by Absci. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Absci
Industry
Industries served
- Biotechnology
Products
Capabilities
Absci's generative AI designs antibody sequences and developability properties in silico, iterating with high-throughput experimental validation that feeds back into model training…
Features
- Integrated Drug Creation platform combining generative AI, wet-lab validation, and proprietary pipeline programs includin
- generative AI
- wet-lab validation
- proprietary pipeline programs including ABS-101 (anti-TL1A)
- ABS-201 (anti-PRLR)
- partner collaborations in dermatology
- immunology
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Partnerships
- August 7, 2025: Almirall expanded AI drug creation collaboration with second dermatology target.
Frequently Asked Questions
What does Absci do?
Absci specializes in artificial intelligence, developing Absci Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Absci based and when was it founded?
Absci is based in United States and was founded in 2011.
What are the main products offered by Absci?
The flagship platform from Absci is Absci Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Absci?
Absci primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.